Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for Prevention of Bronchopulmonary Dysplasia in Preterm Infants
NCT01717625Phase 2Completed
- Sponsor
- Ajou University School of Medicine
- Start
- Nov 2011
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of montelukast in bronchopulmonary dysplasia (BPD) (2 arms), sponsored by Ajou University School of Medicine. Primary endpoint: Incidence of moderate to severe Bronchopulmonary Dysplasia or mortality. Started Nov 2011; status: completed.
02
Drugs
montelukast
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT01717625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01717625.